Find a Tender
complete
Official procurement procedure
NP47818 Glatiramer Injection
Medicinal products for the nervous system
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"): "NP47818 Glatiramer Injection". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
9.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 974 active published awards; 798 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published8 Jul 2022, 14:09 BST | Last source update8 Jul 2022, 14:09 BST | Recurring procurementNot published |
ClassificationMedicinal products for the nervous system, Pharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-02f9a0 | ||
What is being bought
The Framework Agreement is for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to NHS Scotland.
Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioning Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.
What changed
From the official release history
- Official notice release published
8 Jul 2022, 14:09 BST - Status changed to complete
24 Nov 2021, 11:25 GMT - Official notice release published
24 Nov 2021, 11:25 GMT - Buyer information updated
24 Nov 2021, 11:25 GMT
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.Status not publishedPublished valueNot publishedThis Lot is for the supply of 20mg and 40mg Glatiramer Acetate Injection direct to hospitals or direct to patients in their own home, or other designated address, via a manufacturer commissioned Home Delivery Service.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Glatiramer Acetate Injection excluding a manufacturer commissioning Home Delivery ServiceStatus not publishedPublished valueNot publishedThis Lot is for the supply of 20mg and 40mg glatiramer acetate injection direct to hospitals or nominated Home Delivery supplier(s) as directed by Participating Authorities and/or the Authority.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
8 Jul 2022, 14:09 BST - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 4 Jul 2022, 00:00 BST · £500,243 - Contract active
Signed 4 Jul 2022, 00:00 BST · £500,243
Commercial outcome and competition
Awards Mylan Not published · Not published · active Teva UK Limited Not published · Not published · active |
Contracts Glatiramer Acetate Injection excluding a manufacturer commissioning Home Delivery Service £500,243 · signed 4 Jul 2022, 00:00 BST · active Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service. £500,243 · signed 4 Jul 2022, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contracting authority GB-FTS-322Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThis VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 |